Skin Cancer Awareness Month aims to raise awareness about prevention measures against the most common form of cancer. The death rates from skin cancers, particularly melanoma, continue to rise, largely due to the resistance of tumours to existing drugs.
The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the problem is not given enough attention.
This guest post comes from Niranjan Konduri, Principal Technical Advisor in the USAID Systems for Improved Access to Pharmaceuticals and Services Program, Management Sciences for Health.